South Centre

When Medicines Don’t Work Anymore

The growing crisis of antibiotic resistance is catching the attention of policy-makers, but not at a fast enough rate to tackle it. More diseases are affected by resistance, meaning the bacteria cannot be killed even if different drugs are used on some patients, who then succumb.

WTO: Stingy with the Poor, Generous with the Rich

A fight taking place in the World Trade Organisation (WTO) negotiations towards the Bali Ministerial Conference shows how the rules on agriculture allow developed countries to continue to shell out huge subsidies while penalising farmers in developing countries.

Poverty Declines as Inequality Deepens

As world leaders from 193 countries evaluate the successes and failures of the Millennium Development Goals (MDGs) during high-level meetings and special events here, the United Nations claims that extreme poverty worldwide has been cut in half.

The Role of the State in Developing Countries under Attack from New FTAs

Two new trade agreements involving the two economic giants, the United States and the European Union, are leading a charge against the role of the state in the economy of developing countries.

Global Value Chains from a Development Perspective

The current discourse on Global Value Chains by key proponents and also the World Trade Organisation (WTO) secretariat is that developing countries should liberalise - in goods and services - and conclude a trade facilitation agreement.

Are Middle Class Protests Fallout from Poverty Alleviation?

The rise of the "global middle class" is widely attributed to the gradual eradication of extreme poverty in the developing world, even as the United Nations says that millions of people in countries such as India, China and Brazil have graduated from the ranks of the indigent.

Q&A: A Healthy Verdict from India

India’s refusal to grant patent protection for the anti-cancer drug Glivec, developed by Swiss drugmaker Novartis, is a victory for the developing world, which depends on low-cost exports of generic medicines from the Asian giant, said public health specialist Germán Velásquez.